Psychiatry Research
Volume 150, Issue 2 , Pages 211-216 , 30 March 2007

Baseline level of platelet-leukocyte aggregates, platelet CD63 expression, and soluble P-selectin concentration in patientswith posttraumatic stress disorder: A pilot study

  • Anđelko Vidović

      Affiliations

    • Department for Cellular Immunology, Institute of Immunology, Rockefellerova 10, HR-10 000 Zagreb, Croatia
    • Corresponding Author InformationCorresponding author. Tel.: +385 1 4684 309; fax: +385 1 4684 303.
    • ,
  • Maja Vilibić

      Affiliations

    • University Department of Psychiatry, Psychiatric Hospital Vrapče, Bolnička cesta 32, HR-10 090 Zagreb, Croatia
    • ,
  • Alemka Markotić

      Affiliations

    • Department for Cellular Immunology, Institute of Immunology, Rockefellerova 10, HR-10 000 Zagreb, Croatia
    • ,
  • Ante Sabioncello

      Affiliations

    • Department for Cellular Immunology, Institute of Immunology, Rockefellerova 10, HR-10 000 Zagreb, Croatia
    • ,
  • Katja Gotovac

      Affiliations

    • Department for Cellular Immunology, Institute of Immunology, Rockefellerova 10, HR-10 000 Zagreb, Croatia
    • ,
  • Vera Folnegović-Šmalc

      Affiliations

    • University Department of Psychiatry, Psychiatric Hospital Vrapče, Bolnička cesta 32, HR-10 090 Zagreb, Croatia
    • ,
  • Dragan Dekaris

      Affiliations

    • Department for Cellular Immunology, Institute of Immunology, Rockefellerova 10, HR-10 000 Zagreb, Croatia

Received 4 January 2006 ,Revised 17 February 2006 ,Accepted 3 May 2006.

References 

  1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 4th ed.. Washington, DC: American Psychiatric Press; 1994;
  2. Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Keane TM. Clinician-Administered PTSD Scale for DSM-IV. Current and Lifetime Diagnostic Version (CAPS-DX). Boston and West Haven: National Center for Posttraumatic Stress Disorder; 1996;
  3. Blanchard EB, Kolb LC, Prins A, Gates S, McCoy GC. Changes in plasma norepinephrine to combat-related stimuli among Vietnam veterans with posttraumatic stress disorder. Journal of Nervous and Mental Disease. 1991;179:371–373
  4. Blann AD, Nadar SK, Lip GY. The adhesion molecule P-selectin and cardiovascular disease. European Heart Journal. 2003;24:2166–2179
  5. Boscarino JA, Chang J. Electrocardiogram abnormalities among men with stress-related psychiatric disorders: implications for coronary heart disease and clinical research. Annals of Behavioral Medicine: a Publication of the Society of Behavioral Medicine. 1999;21:227–234
  6. Bruce EC, Musselman DL. Depression, alterations in platelet function, and ischemic heart disease. Psychosomatic Medicine. 2005;67(Suppl 1):S34–S36
  7. Brydon L, Magid K, Steptoe A. Platelets, coronary heart disease, and stress. Brain, Behavior, and Immunity. 2006;20:113–119
  8. Buckley TC, Kaloupek DG. A meta-analytic examination of basal cardiovascular activity in posttraumatic stress disorder. Psychosomatic Medicine. 2001;63:585–594
  9. Caine GJ, Blann AD. Soluble p-selectin should be measured in citrated plasma, not in serum. British Journal of Haematology. 2003;121:530–532
  10. Camacho A, Dimsdale JE. Platelets and psychiatry: lessons learned from old and new studies. Psychosomatic Medicine. 2000;62:326–336
  11. Cicin-Sain L, Mimica N, Hranilovic D, Balija M, Ljubin T, Makaric G, et al. Posttraumatic stress disorder and platelet serotonin measures. Journal of Psychiatric Research. 2000;34:155–161
  12. Falger PR, Op den VeW, Hovens JE, Schouten EG, De Groen JH, Van Duijn H. Current posttraumatic stress disorder and cardiovascular disease risk factors in Dutch Resistance veterans from World War II. Psychotherapy and Psychosomatics. 1992;57:164–171
  13. Furman MI, Benoit SE, Barnard MR, Valeri CR, Borbone ML, Becker RC, et al. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. Journal of the American College of Cardiology. 1998;31:352–358
  14. Gavish M, Laor N, Bidder M, Fisher D, Fonia O, Muller U, et al. Altered platelet peripheral-type benzodiazepine receptor in posttraumatic stress disorder. Neuropsychopharmacology. 1996;14:181–186
  15. Guy W. Clinical Global Impressions. In:  Guy W editors. ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: National Institute of Mental Health; 1976;p. 218–222
  16. Israels SJ, McMillan-Ward EM. CD63 modulates spreading and tyrosine phosphorylation of platelets on immobilized fibrinogen. Thrombosis and Haemostasis. 2005;93:311–318
  17. Israels SJ, McMillan-Ward EM, Easton J, Robertson C, McNicol A. CD63 associates with the alphaIIb beta3 integrin-CD9 complex on the surface of activated platelets. Thrombosis and Haemostasis. 2001;85:134–141
  18. Kozaric-Kovacic D, Ljubin T, Rutic-Puz L, Mihaljevic J, Jernej B, Cicin-Sain L. Platelet monoamine oxidase activity, ego strength, and neuroticism in soldiers with combat-related current posttraumatic stress disorder. Croatian Medical Journal. 2000;41:76–80
  19. Lederbogen F, Baranyai R, Gilles M, Menart-Houtermans B, Tschoepe D, Deuschle M. Effect of mental and physical stress on platelet activation markers in depressed patients and healthy subjects: a pilot study. Psychiatry Research. 2004;127:55–64
  20. Lerer B, Ebstein RP, Shestatsky M, Shemesh Z, Greenberg D. Cyclic AMP signal transduction in posttraumatic stress disorder. American Journal of Psychiatry. 1987;144:1324–1327
  21. Li N, Goodall AH, Hjemdahl P. Efficient flow cytometric assay for platelet-leukocyte aggregates in whole blood using fluorescence signal triggering. Cytometry. 1999;35:154–161
  22. Michelson AD, Barnard MR, Hechtman HB, MacGregor H, Connolly RJ, Loscalzo J, et al. In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proceedings of the National Academy of Sciences of the United States of America. 1996;93:11877–11882
  23. Michelson AD, Barnard MR, Krueger LA, Frelinger AL, Furman MI. Evaluation of platelet function by flow cytometry. Methods. 2000;21:259–270
  24. Michelson AD, Barnard MR, Krueger LA, Valeri CR, Furman MI. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation. 2001;104:1533–1537
  25. Nijm J, Wikby A, Tompa A, Olsson AG, Jonasson L. Circulating levels of proinflammatory cytokines and neutrophil-platelet aggregates in patients with coronary artery disease. American Journal of Cardiology. 2005;95:452–456
  26. Pasic J, Sullivan MD, Russo J, Chandler WL, Levy WC. Lack of depression effect on platelet activation in patients with heart failure. Psychiatry Research. 2004;129:289–292
  27. Perry BD, Giller EL, Southwick SM. Altered platelet alpha 2-adrenergic binding sites in posttraumatic stress disorder. American Journal of Psychiatry. 1987;144:1511–1512
  28. Pivac N, Muck-Seler D, Sagud M, Jakovljevic M. Platelet serotonergic markers in posttraumatic stress disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2002;26:1193–1198
  29. Rinder HM, Bonan JL, Rinder CS, Ault KA, Smith BR. Activated and unactivated platelet adhesion to monocytes and neutrophils. Blood. 1991;78:1760–1769
  30. Rozanski A, Blumenthal JA, Davidson KW, Saab PG, Kubzansky L. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. Journal of the American College of Cardiology. 2005;45:637–651
  31. Semenov AV, Romanov YA, Loktionova SA, Tikhomirov OY, Khachikian MV, Vasil'ev SA, et al. Production of soluble P-selectin by platelets and endothelial cells. Biochemistry (Moscow). 1999;64:1326–1335
  32. Serebruany VL, Glassman AH, Malinin AI, Sane DC, Finkel MS, Krishnan RR, et al. Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes: evidence from recent clinical trials. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis. 2003;14:563–567
  33. Sibai AM, Armenian HK, Alam S. Wartime determinants of arteriographically confirmed coronary artery disease in Beirut. American Journal of Epidemiology. 1989;130:623–631
  34. Southwick SM, Paige S, Morgan CA, Bremner JD, Krystal JH, Charney DS. Neurotransmitter alterations in PTSD: catecholamines and serotonin. Seminars in Clinical Neuropsychiatry. 1999;4:242–248
  35. Steptoe A, Magid K, Edwards S, Brydon L, Hong Y, Erusalimsky J. The influence of psychological stress and socioeconomic status on platelet activation in men. Atherosclerosis. 2003;168:57–63
  36. Thom J, Gilmore G, Yi Q, Hankey GJ, Eikelboom JW. Measurement of soluble P-selectin and soluble CD40 ligand in serum and plasma. Journal of Thrombosis and Haemostasis: JTH. 2004;2:2067–2069
  37. von Kanel R. Platelet hyperactivity in clinical depression and the beneficial effect of antidepressant drug treatment: how strong is the evidence?. Acta Psychiatrica Scandinavica. 2004;110:163–177
  38. von Kanel R, Dimsdale JE. Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. European Journal of Haematology. 2000;65:357–369
  39. Walsh MT, Dinan TG, Condren RM, Ryan M, Kenny D. Depression is associated with an increase in the expression of the platelet adhesion receptor glycoprotein Ib. Life Sciences. 2002;70:3155–3165
  40. Walsh MT, Ryan M, Hillmann A, Condren R, Kenny D, Dinan T, et al. Elevated expression of integrin alpha(IIb) beta(IIIa) in drug-naive, first-episode schizophrenic patients. Biological Psychiatry. 2002;52:874–879
  41. World Health Organization . The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines, Geneva. 1992;
  42. Yehuda R, Southwick S, Giller EL, Ma X, Mason JW. Urinary catecholamine excretion and severity of PTSD symptoms in Vietnam combat veterans. Journal of Nervous and Mental Disease. 1992;180:321–325
  43. Yehuda R, Siever LJ, Teicher MH, Levengood RA, Gerber DK, Schmeidler J, et al. Plasma norepinephrine and 3-methoxy-4-hydroxyphenylglycol concentrations and severity of depression in combat posttraumatic stress disorder and major depressive disorder. Biological Psychiatry. 1998;44:56–63

PII: S0165-1781(06)00118-1

doi: 10.1016/j.psychres.2006.05.004

Psychiatry Research
Volume 150, Issue 2 , Pages 211-216 , 30 March 2007

Article Tools